{"id":2688,"date":"2019-05-14T14:53:57","date_gmt":"2019-05-14T04:53:57","guid":{"rendered":"\/eu-uk\/?p=2688"},"modified":"2021-10-21T14:55:42","modified_gmt":"2021-10-21T04:55:42","slug":"orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study","status":"publish","type":"post","link":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/","title":{"rendered":"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study"},"content":{"rendered":"<p>Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients regain sensation and muscle function following Celgro\u2122 nerve regeneration treatment.<\/p>\n<p>Read the article <a href=\"https:\/\/www.bioworld.com\/articles\/436849\">HERE.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients regain sensation and muscle function following Celgro\u2122 nerve regeneration treatment.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-2688","post","type-post","status-publish","format-standard","hentry","category-media"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.9 - aioseo.com -->\n\t<meta name=\"description\" content=\"Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients regain sensation and muscle function following Celgro\u2122 nerve regeneration treatment.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Orthocell\"\/>\n\t<link rel=\"canonical\" href=\"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.9\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_GB\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Orthocell EU\/UK -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study - Orthocell EU\/UK\" \/>\n\t\t<meta property=\"og:description\" content=\"Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients regain sensation and muscle function following Celgro\u2122 nerve regeneration treatment.\" \/>\n\t\t<meta property=\"og:url\" content=\"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2019-05-14T04:53:57+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2021-10-21T04:55:42+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study - Orthocell EU\/UK\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients regain sensation and muscle function following Celgro\u2122 nerve regeneration treatment.\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2019\\\/05\\\/14\\\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\\\/#blogposting\",\"name\":\"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study - Orthocell EU\\\/UK\",\"headline\":\"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study\",\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"},\"datePublished\":\"2019-05-14T14:53:57+10:00\",\"dateModified\":\"2021-10-21T14:55:42+10:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2019\\\/05\\\/14\\\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2019\\\/05\\\/14\\\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\\\/#webpage\"},\"articleSection\":\"Media\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2019\\\/05\\\/14\\\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/media\\\/#listItem\",\"name\":\"Media\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/media\\\/#listItem\",\"position\":2,\"name\":\"Media\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/media\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2019\\\/05\\\/14\\\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\\\/#listItem\",\"name\":\"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2019\\\/05\\\/14\\\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\\\/#listItem\",\"position\":3,\"name\":\"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/media\\\/#listItem\",\"name\":\"Media\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\",\"name\":\"Orthocell EU\\\/UK\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/\",\"name\":\"Orthocell\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2019\\\/05\\\/14\\\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Orthocell\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2019\\\/05\\\/14\\\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\\\/#webpage\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2019\\\/05\\\/14\\\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\\\/\",\"name\":\"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study - Orthocell EU\\\/UK\",\"description\":\"Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients regain sensation and muscle function following Celgro\\u2122 nerve regeneration treatment.\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2019\\\/05\\\/14\\\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"datePublished\":\"2019-05-14T14:53:57+10:00\",\"dateModified\":\"2021-10-21T14:55:42+10:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\",\"name\":\"Orthocell EU\\\/UK\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study - Orthocell EU\/UK","description":"Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients regain sensation and muscle function following Celgro\u2122 nerve regeneration treatment.","canonical_url":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/#blogposting","name":"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study - Orthocell EU\/UK","headline":"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study","author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"publisher":{"@id":"\/eu-uk\/#organization"},"datePublished":"2019-05-14T14:53:57+10:00","dateModified":"2021-10-21T14:55:42+10:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/#webpage"},"isPartOf":{"@id":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/#webpage"},"articleSection":"Media"},{"@type":"BreadcrumbList","@id":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","position":1,"name":"Home","item":"https:\/\/orthocell.com\/eu-uk","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/media\/#listItem","name":"Media"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/media\/#listItem","position":2,"name":"Media","item":"\/eu-uk\/blog\/category\/media\/","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/#listItem","name":"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study"},"previousItem":{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","name":"Home"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/#listItem","position":3,"name":"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study","previousItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/media\/#listItem","name":"Media"}}]},{"@type":"Organization","@id":"\/eu-uk\/#organization","name":"Orthocell EU\/UK","url":"\/eu-uk\/"},{"@type":"Person","@id":"\/eu-uk\/blog\/author\/hcartres\/#author","url":"\/eu-uk\/blog\/author\/hcartres\/","name":"Orthocell","image":{"@type":"ImageObject","@id":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g","width":96,"height":96,"caption":"Orthocell"}},{"@type":"WebPage","@id":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/#webpage","url":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/","name":"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study - Orthocell EU\/UK","description":"Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients regain sensation and muscle function following Celgro\u2122 nerve regeneration treatment.","inLanguage":"en-GB","isPartOf":{"@id":"\/eu-uk\/#website"},"breadcrumb":{"@id":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/#breadcrumblist"},"author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"creator":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"datePublished":"2019-05-14T14:53:57+10:00","dateModified":"2021-10-21T14:55:42+10:00"},{"@type":"WebSite","@id":"\/eu-uk\/#website","url":"\/eu-uk\/","name":"Orthocell EU\/UK","inLanguage":"en-GB","publisher":{"@id":"\/eu-uk\/#organization"}}]},"og:locale":"en_GB","og:site_name":"Orthocell EU\/UK -","og:type":"article","og:title":"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study - Orthocell EU\/UK","og:description":"Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients regain sensation and muscle function following Celgro\u2122 nerve regeneration treatment.","og:url":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/","article:published_time":"2019-05-14T04:53:57+00:00","article:modified_time":"2021-10-21T04:55:42+00:00","twitter:card":"summary_large_image","twitter:title":"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study - Orthocell EU\/UK","twitter:description":"Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients regain sensation and muscle function following Celgro\u2122 nerve regeneration treatment."},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/orthocell.com\/eu-uk\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"\/eu-uk\/blog\/category\/media\/\" title=\"Media\">Media<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tOrthocell shares spike 350% following interim results of Celgro nerve regeneration study\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/orthocell.com\/eu-uk"},{"label":"Media","link":"\/eu-uk\/blog\/category\/media\/"},{"label":"Orthocell shares spike 350% following interim results of Celgro nerve regeneration study","link":"\/eu-uk\/blog\/2019\/05\/14\/orthocell-shares-spike-350-following-interim-results-of-celgro-nerve-regeneration-study\/"}],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/2688","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=2688"}],"version-history":[{"count":1,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/2688\/revisions"}],"predecessor-version":[{"id":2689,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/2688\/revisions\/2689"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=2688"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=2688"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=2688"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}